Document Detail

Antihypertensive effects and safety of eprosartan: a meta-analysis of randomized controlled trials.
MedLine Citation:
PMID:  21881888     Owner:  NLM     Status:  Publisher    
PURPOSE: The benefits of reducing blood pressure (BP) have been well established, but uncertainty remains about the comparative effects of different BP-lowering regimens. We aimed to estimate the efficacy and the tolerability of eprosartan compared with other agents as monotherapy. METHODS: PubMed, EMBASE, and Cochrane Library were searched for relevant studies. A meta-analysis of randomized controlled trials (RCTs) meeting the criteria was performed using Review Manager and Stata/SE. RESULTS: Twenty-two articles were ultimately included out of 78 studies, involving 6,460 patients. Eprosartan had a greater systolic blood pressure (SBP) reduction than placebo [weighted mean difference (WMD): 6.55, 95% confidence interval (CI) 4.86-8.25] and losartan (WMD: 2.24, 95% CI 0.08-4.40) and a greater diastolic blood pressure (DBP) reduction than placebo (WMD 3.95, 95% CI 2.77-5.13). Therapeutic response rate of BP favored eprosartan [risk ratio (RR) 1.13, 95% CI 1.03-1.24] compared with enalapril. There were no statistical differences in SBP or DBP reductions comparing eprosartan with enalapril or telmisartan. Original RCTs included comparing eprosartan with valsartan and nitrendipine reported no differences in BP-lowering efficacy. CONCLUSIONS: Eprosartan monotherapy is equivalent to many first-line antihypertensive agents and is effective for the treatment of essential hypertension, especially for isolated systolic hypertension. The favorable efficacy and tolerability make eprosartan worthwhile to be taken into consideration by physicians.
Feng-Ying Xu; Bo Yang; Duo Shi; Hao Li; Zui Zou; Xue-Yin Shi
Related Documents :
9073008 - Cardiovascular consequences of fibreoptic bronchoscopy.
23664548 - Blood pressure, proteinuria, and phosphate as risk factors for progressive kidney disea...
3169228 - Variability of the single-breath carbon monoxide transfer factor as a function of inspi...
21470588 - Disjoining pressure and capillarity in the constrained vapor bubble heat transfer system.
9445278 - Determination of total effective vascular compliance in patients with sepsis syndrome.
12070398 - Treatment of pressure ulcers in a rehabilitation ward.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-9-1
Journal Detail:
Title:  European journal of clinical pharmacology     Volume:  -     ISSN:  1432-1041     ISO Abbreviation:  -     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-9-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1256165     Medline TA:  Eur J Clin Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Company of Anesthesiology, Second Military Medical University, 800 Xiangyin Road, Shanghai, 200433, People's Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluation of methods for achieving stable INR in healthy subjects during a multiple-dose warfarin s...
Next Document:  Reconstruction and verification of a genome-scale metabolic model for Synechocystis sp. PCC6803.